283 related articles for article (PubMed ID: 30126842)
1. Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.
Duggimpudi S; Kloetgen A; Maney SK; Münch PC; Hezaveh K; Shaykhalishahi H; Hoyer W; McHardy AC; Lang PA; Borkhardt A; Hoell JI
J Biol Chem; 2018 Oct; 293(40):15359-15369. PubMed ID: 30126842
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration.
Bennett CG; Riemondy K; Chapnick DA; Bunker E; Liu X; Kuersten S; Yi R
Nucleic Acids Res; 2016 May; 44(8):3788-800. PubMed ID: 27034466
[TBL] [Abstract][Full Text] [Related]
3. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
Zhang H; Tan S; Wang J; Chen S; Quan J; Xian J; Zhang Ss; He J; Zhang L
Exp Cell Res; 2014 Jan; 320(1):119-27. PubMed ID: 24076374
[TBL] [Abstract][Full Text] [Related]
4. Control of gp130 expression by the mitogen-activated protein kinase ERK2.
Bonito NA; Drechsler J; Stoecker S; Carmo CR; Seckl MJ; Hermanns HM; Costa-Pereira AP
Oncogene; 2014 Apr; 33(17):2255-63. PubMed ID: 23686311
[TBL] [Abstract][Full Text] [Related]
5. HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells.
Nguyen DTT; Lu Y; Chu KL; Yang X; Park SM; Choo ZN; Chin CR; Prieto C; Schurer A; Barin E; Savino AM; Gourkanti S; Patel P; Vu LP; Leslie CS; Kharas MG
Nat Commun; 2020 Apr; 11(1):2026. PubMed ID: 32332729
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-α
Convery O; Gargan S; Kickham M; Schroder M; O'Farrelly C; Stevenson NJ
FASEB J; 2019 Aug; 33(8):8732-8744. PubMed ID: 31163989
[TBL] [Abstract][Full Text] [Related]
8. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
[TBL] [Abstract][Full Text] [Related]
9. LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling.
Greenhill CJ; Gould J; Ernst M; Jarnicki A; Hertzog PJ; Mansell A; Jenkins BJ
Immunol Cell Biol; 2012 May; 90(5):559-63. PubMed ID: 21670738
[TBL] [Abstract][Full Text] [Related]
10. Dynamic interplay of two molecular switches enabled by the MEK1/2-ERK1/2 and IL-6-STAT3 signaling axes controls epithelial cell migration in response to growth factors.
Qin L; Cao X; Kaneko T; Voss C; Liu X; Wang G; Li SS
J Biol Chem; 2021 Oct; 297(4):101161. PubMed ID: 34480897
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.
Li F; Han Y; Chen R; Jiang Y; Chen C; Wang X; Zhou J; Xu Q; Jiang S; Zhang S; Yu K; Zhang S
J Transl Med; 2023 May; 21(1):309. PubMed ID: 37149661
[TBL] [Abstract][Full Text] [Related]
12. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
13. Signal transducer and activator of transcription 3-A key molecular switch for human mesenchymal stem cell proliferation.
Levy O; Dvir T; Tsur-Gang O; Granot Y; Cohen S
Int J Biochem Cell Biol; 2008; 40(11):2606-18. PubMed ID: 18583177
[TBL] [Abstract][Full Text] [Related]
14. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.
Aydemir MN; Aydemir HB; Korkmaz EM; Budak M; Cekin N; Pinarbasi E
Gene Rep; 2021 Mar; 22():101012. PubMed ID: 33398248
[TBL] [Abstract][Full Text] [Related]
15. The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner.
Bongartz H; Gille K; Hessenkemper W; Mandel K; Lewitzky M; Feller SM; Schaper F
Cell Commun Signal; 2019 Oct; 17(1):135. PubMed ID: 31651330
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of TrkA in cumulus oocyte complexes (COCs) inhibits EGF-induced cumulus expansion by down-regulation of IL-6.
Wang Y; Liang N; Yao G; Tian H; Zhai Y; Yin Y; Sun F
Mol Cell Endocrinol; 2014 Feb; 382(2):804-13. PubMed ID: 24215827
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Reg I-induced β-cell apoptosis by IL-6/dexamethasone through activation of HGF gene regulation.
Nakagawa K; Takasawa S; Nata K; Yamauchi A; Itaya-Hironaka A; Ota H; Yoshimoto K; Sakuramoto-Tsuchida S; Miyaoka T; Takeda M; Unno M; Okamoto H
Biochim Biophys Acta; 2013 Dec; 1833(12):2988-2995. PubMed ID: 23954444
[TBL] [Abstract][Full Text] [Related]
18. Induction of interleukin-8 secretion and activation of ERK1/2, p38 MAPK signaling pathways by thrombin in dermal fibroblasts.
Wang L; Luo J; Fu Y; He S
Int J Biochem Cell Biol; 2006; 38(9):1571-83. PubMed ID: 16697690
[TBL] [Abstract][Full Text] [Related]
19. Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1.
Lan L; Xing M; Kashipathy M; Douglas J; Gao P; Battaile K; Hanzlik R; Lovell S; Xu L
Proteins; 2020 Apr; 88(4):573-583. PubMed ID: 31603583
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
